Stifel raises Agilent stock price target to $180 on strong quarter

Agilent Technologies Inc. (NYSE:A) experienced a stronger-than-anticipated third quarter, with its shares receiving a price target increase from Stifel to $180 from $170, while maintaining a Buy rating. The firm highlighted the company's robust performance, driven by growth in LC-MS (low double-digit) and Advanced Therapeutics (approximately 30%).

Instrumentation saw high-single-digit growth, and semiconductor demand along with PFAS testing contributed to overall gains. Agilent's margins improved by 320 basis points year-over-year, benefiting from volume leverage and the Ignite program. Analysts anticipate 6% organic growth for the year and more than 6% next year. Despite a current P/E ratio of 30.86 and revenue growth of 9%, Stifel believes the stock is overvalued relative to its Fair Value, trading at 23 times fiscal 2027 earnings.

Agilent exceeded expectations in its fiscal third quarter, reporting adjusted earnings of $1.62 per share and revenue of $1.88 billion, surpassing Wall Street forecasts. The company also raised its full-year outlook for revenue, profit, and margins, reflecting confidence in its ongoing performance and strong demand in pharmaceuticals and applied markets, particularly in China.

This positive news highlights Agilent's ability to navigate market dynamics effectively, garnering attention from investors.